Abstract:Abstract There are 5.7 million people in the United States with heart failure, which is life-limiting in 20% of patients. 1 While data is most robust in the United States for this cohort, it is known to be a global problem with over 23 million people carrying the diagnosis. 1 For end-stage heart failure, many require a heart transplantation, however, there is a shortage in the supply of organ donors. Cardiac xenotransplantation has been proposed to “bridge the gap” in supply for these patients requiring transplantation. Recent pre-clinical success using genetically modified pig donors in baboon recipients has demonstrated survival greater than 6 months. 2–5 First-in-human transplantation of a genetically modified pig kidney demonstrated 54 hour rejection-free function when perfused by a deceased human recipient, demonstrating the feasibility of cross-species transplantation and invigorating enthusiasm further to utilize this new organ source for a population that would otherwise die waiting for a human organ. 6 While this human study demonstrated proof-of-principle of overcoming hyperacute rejection, further regulatory oversight by Food and Drug Administration (FDA) may be required with pre-clinical trials in large animal models of xenotransplantation with long-term survival. These studies not only require a multi-disciplinary team and expertise in orthotopic transplantation (cardiac surgery, anesthesia and cardiopulmonary bypass), immunology and genetic engineering; but also, specifically handling large animal recipients that cannot communicate their symptoms. Here we detail our approach to pig-to-primate large animal model of orthotopic cardiac xenotransplantation perioperatively and in the months thereafter in long-term surviving animals. We also detail xenograft surveillance methods and common issues that arise in the postoperative period specific to this model and ways to overcome them.

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia

Introduction of Modified Cervical Cardiac Transplant Model in Mice.

Improved Technique of Heterotopic Abdominal Heart Transplantation in Mice

A Novel and Knotless Technique for Heterotopic Cardiac Transplantation in Mice

Mouse Heterotopic Abdominal Heart Transplant Model

A Modified Technique for Heterotopic Heart Transplantation in Rats.

Improved Techniques for Murine Model of Cardiac Transplantation

Modified Technique for Heterotopic Rat Heart Transplantation under Cardioplegic Arrest.

Improved Technique of Heterotopic Heart Transplantation Model in Rats

A Simple Cuff Technique for Murine Left Lung Transplantation

Novel Technique for Blood Circuit Reconstruction in Mouse Heart Transplantation Model.

A Standardized Approach to Orthotopic (Life-supporting) Porcine Cardiac Xenotransplantation in a Nonhuman Primate Model

A Modified Splint Tubing Technique for Heterotopic Heart Transplantation in Mouse

Technique for retransplanting heterotopic heart grafts in mice.

Improved Technique of Mouse Heterotopic Heart Graft Retransplantation

A Standardized Approach to Orthotopic (Life-Supporting) Porcine Cardiac Xenotransplantation in a Non-Human Primate Model

Organ Transplantation in Rodents: Novel Applications of Long-Established Methods

Animal Models for Heart Transplantation Focusing on the Pathological Conditions

Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunction

Establishment and improvement of allogeneic rat models of heterotopic cardiac transplantation

Establishment of a Model of Pig-to-monkey Abdominal Heterotopic Cardiac Xenotransplantation